Avandia, a Case of Deja Vu all over again
Similar Posts
VIOXX – Merck–MEDCO – a case study
VIOXX – Merck–MEDCO – a case study Wed, 13 Oct 2004 Vioxx: A case study in how a lethal drug is marketed and dispensed – without MINIMAL safeguards to protect people’s lives. Merck marketed and sold billions of dollars worth of Vioxx through MEDCO–the largest Medicare Pharmacy Benefit Manager (PBM)…
More than 100 top regulatory officials represented industry as lobbyists, lawyers… – Denver Post
More than 100 top regulatory officials represented industry as lobbyists, lawyers… – Denver Post Mon, 24 May 2004 To understand why government policies affecting healthcare, drug safety, food safety and the environment appear to promote industry interests at the expense of public safety and health, the Denver Post has investigated…
SSRI Prescription For Murder? Interrogation Methods Can Elicit Confessions From Innocent People
SSRI Prescription For Murder? CBS News 48 Hours / Interrogation Methods Can Elicit Confessions From Innocent People Sat, 16 Apr 2005 CBS News is broadcasting the Christopher Pittman story–the 16 year old who was tried for murder as an adult for a crime he committed as a 12 year old…
Depression-Serotonin: How Did So Many Smart People Get it So Wrong?_WSJ
"Serotonin and depression: A disconnect between the advertisements and the scientific literature."
"Some 19 million people in the U.S. suffer from depression in any given year. For many, SSRIs help little, if at all. To do better, we have to get the science right." Sharon Begley, Wall Street Journal
- Concealed Data | Conflict of Interest | Current Controversies | Hazards | Psych Drugs | Vulnerable Groups
MAD IN AMERICA – important new book
January 7, 2002 FYI MAD IN AMERICA (Perseus Press), a new book by Robert Whitaker, a prize winning science journalist, is sure to cause a stir. Whitaker holds psychiatry’s feet to the fire by examining the evidence in the professional psychiatric literature, FDA documents, published treatment outcome studies–including the World…
Guidant Didn’t Disclose a Flaw in Defibrillator for 3 Years – NYT / FDA Wrong on Crestor Safety
Guidant Didn’t Disclose a Flaw in Defibrillator for 3 Years_NYT / FDA Wrong on Crestor Safety Tue, 24 May 2005 The New York Times reports that the maker a a heart defirillator knew for 3 years about a malfunction and failed to inform physicians about It because the company “had…